nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A2—Carmustine—malignant glioma	0.223	0.57	CbGbCtD
Pentamidine—CYP3A4—Temozolomide—malignant glioma	0.168	0.43	CbGbCtD
Pentamidine—S100B—vertebral column—malignant glioma	0.0335	0.32	CbGeAlD
Pentamidine—Hemianopia—Temozolomide—malignant glioma	0.0226	0.0951	CcSEcCtD
Pentamidine—S100B—blood vessel—malignant glioma	0.0137	0.131	CbGeAlD
Pentamidine—Leg edema—Temozolomide—malignant glioma	0.00966	0.0407	CcSEcCtD
Pentamidine—AOC1—embryo—malignant glioma	0.0094	0.0899	CbGeAlD
Pentamidine—S100B—brainstem—malignant glioma	0.00751	0.0718	CbGeAlD
Pentamidine—S100B—retina—malignant glioma	0.00724	0.0693	CbGeAlD
Pentamidine—Ospemifene—CYP2B6—malignant glioma	0.00683	1	CrCbGaD
Pentamidine—S100B—telencephalon—malignant glioma	0.00666	0.0637	CbGeAlD
Pentamidine—Interstitial pneumonia—Temozolomide—malignant glioma	0.00538	0.0227	CcSEcCtD
Pentamidine—Azotaemia—Carmustine—malignant glioma	0.00505	0.0213	CcSEcCtD
Pentamidine—S100B—midbrain—malignant glioma	0.00478	0.0458	CbGeAlD
Pentamidine—S100B—spinal cord—malignant glioma	0.00467	0.0446	CbGeAlD
Pentamidine—Oral candidiasis—Carmustine—malignant glioma	0.00424	0.0179	CcSEcCtD
Pentamidine—Oral candidiasis—Temozolomide—malignant glioma	0.00409	0.0173	CcSEcCtD
Pentamidine—Paranoia—Carmustine—malignant glioma	0.00395	0.0166	CcSEcCtD
Pentamidine—Interstitial lung disease—Carmustine—malignant glioma	0.0038	0.016	CcSEcCtD
Pentamidine—S100B—central nervous system—malignant glioma	0.00379	0.0362	CbGeAlD
Pentamidine—S100B—cerebellum—malignant glioma	0.0037	0.0354	CbGeAlD
Pentamidine—Interstitial lung disease—Temozolomide—malignant glioma	0.00367	0.0155	CcSEcCtD
Pentamidine—Lung disorder—Temozolomide—malignant glioma	0.00367	0.0155	CcSEcCtD
Pentamidine—Herpes zoster—Temozolomide—malignant glioma	0.00345	0.0146	CcSEcCtD
Pentamidine—Necrosis—Carmustine—malignant glioma	0.00343	0.0145	CcSEcCtD
Pentamidine—Abscess—Carmustine—malignant glioma	0.0034	0.0143	CcSEcCtD
Pentamidine—Extravasation—Carmustine—malignant glioma	0.00308	0.013	CcSEcCtD
Pentamidine—S100B—brain—malignant glioma	0.00301	0.0288	CbGeAlD
Pentamidine—Gait disturbance—Carmustine—malignant glioma	0.00276	0.0116	CcSEcCtD
Pentamidine—Gait disturbance—Temozolomide—malignant glioma	0.00267	0.0112	CcSEcCtD
Pentamidine—Skin exfoliation—Carmustine—malignant glioma	0.00257	0.0108	CcSEcCtD
Pentamidine—Candida infection—Carmustine—malignant glioma	0.00257	0.0108	CcSEcCtD
Pentamidine—Neuropathy—Carmustine—malignant glioma	0.00253	0.0107	CcSEcCtD
Pentamidine—Candida infection—Temozolomide—malignant glioma	0.00248	0.0105	CcSEcCtD
Pentamidine—Skin exfoliation—Temozolomide—malignant glioma	0.00248	0.0105	CcSEcCtD
Pentamidine—Neuropathy—Temozolomide—malignant glioma	0.00244	0.0103	CcSEcCtD
Pentamidine—Sepsis—Carmustine—malignant glioma	0.00234	0.00985	CcSEcCtD
Pentamidine—Phlebitis—Carmustine—malignant glioma	0.00227	0.00956	CcSEcCtD
Pentamidine—Diabetes mellitus—Carmustine—malignant glioma	0.00225	0.00947	CcSEcCtD
Pentamidine—Eye pain—Carmustine—malignant glioma	0.00216	0.00912	CcSEcCtD
Pentamidine—Eye pain—Temozolomide—malignant glioma	0.00209	0.00882	CcSEcCtD
Pentamidine—Amnesia—Carmustine—malignant glioma	0.00208	0.00877	CcSEcCtD
Pentamidine—Nasal congestion—Temozolomide—malignant glioma	0.00207	0.00874	CcSEcCtD
Pentamidine—Amnesia—Temozolomide—malignant glioma	0.00201	0.00847	CcSEcCtD
Pentamidine—Face oedema—Carmustine—malignant glioma	0.00189	0.00795	CcSEcCtD
Pentamidine—Affect lability—Temozolomide—malignant glioma	0.00186	0.00784	CcSEcCtD
Pentamidine—Face oedema—Temozolomide—malignant glioma	0.00182	0.00768	CcSEcCtD
Pentamidine—Liver function test abnormal—Carmustine—malignant glioma	0.0018	0.0076	CcSEcCtD
Pentamidine—Mood swings—Temozolomide—malignant glioma	0.00179	0.00754	CcSEcCtD
Pentamidine—Dry skin—Temozolomide—malignant glioma	0.00173	0.0073	CcSEcCtD
Pentamidine—Pancytopenia—Carmustine—malignant glioma	0.0016	0.00676	CcSEcCtD
Pentamidine—Neutropenia—Carmustine—malignant glioma	0.00158	0.00666	CcSEcCtD
Pentamidine—Bronchitis—Temozolomide—malignant glioma	0.00157	0.00662	CcSEcCtD
Pentamidine—Pancytopenia—Temozolomide—malignant glioma	0.00155	0.00653	CcSEcCtD
Pentamidine—Neutropenia—Temozolomide—malignant glioma	0.00153	0.00643	CcSEcCtD
Pentamidine—Hyperglycaemia—Carmustine—malignant glioma	0.00152	0.00642	CcSEcCtD
Pentamidine—Renal failure—Carmustine—malignant glioma	0.00148	0.00624	CcSEcCtD
Pentamidine—Neuropathy peripheral—Carmustine—malignant glioma	0.00148	0.00622	CcSEcCtD
Pentamidine—Hyperglycaemia—Temozolomide—malignant glioma	0.00147	0.00621	CcSEcCtD
Pentamidine—Stomatitis—Carmustine—malignant glioma	0.00147	0.00619	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00144	0.00608	CcSEcCtD
Pentamidine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00143	0.00601	CcSEcCtD
Pentamidine—Stomatitis—Temozolomide—malignant glioma	0.00142	0.00598	CcSEcCtD
Pentamidine—Sinusitis—Temozolomide—malignant glioma	0.00137	0.00576	CcSEcCtD
Pentamidine—Hypoaesthesia—Carmustine—malignant glioma	0.00134	0.00567	CcSEcCtD
Pentamidine—Hallucination—Carmustine—malignant glioma	0.00134	0.00567	CcSEcCtD
Pentamidine—Oedema peripheral—Carmustine—malignant glioma	0.00133	0.00561	CcSEcCtD
Pentamidine—Hepatitis—Temozolomide—malignant glioma	0.00131	0.00551	CcSEcCtD
Pentamidine—Hallucination—Temozolomide—malignant glioma	0.0013	0.00548	CcSEcCtD
Pentamidine—Hypoaesthesia—Temozolomide—malignant glioma	0.0013	0.00548	CcSEcCtD
Pentamidine—Pharyngitis—Temozolomide—malignant glioma	0.0013	0.00547	CcSEcCtD
Pentamidine—Oedema peripheral—Temozolomide—malignant glioma	0.00129	0.00542	CcSEcCtD
Pentamidine—Flushing—Carmustine—malignant glioma	0.00125	0.00529	CcSEcCtD
Pentamidine—Erythema multiforme—Temozolomide—malignant glioma	0.00124	0.00521	CcSEcCtD
Pentamidine—Flushing—Temozolomide—malignant glioma	0.00121	0.00511	CcSEcCtD
Pentamidine—Arrhythmia—Carmustine—malignant glioma	0.00121	0.00509	CcSEcCtD
Pentamidine—Erythema—Carmustine—malignant glioma	0.00118	0.00496	CcSEcCtD
Pentamidine—Chills—Temozolomide—malignant glioma	0.00117	0.00494	CcSEcCtD
Pentamidine—CYP2D6—brainstem—malignant glioma	0.00117	0.0112	CbGeAlD
Pentamidine—Erythema—Temozolomide—malignant glioma	0.00114	0.00479	CcSEcCtD
Pentamidine—Dysgeusia—Temozolomide—malignant glioma	0.00111	0.00469	CcSEcCtD
Pentamidine—Vision blurred—Carmustine—malignant glioma	0.00111	0.00467	CcSEcCtD
Pentamidine—Tremor—Carmustine—malignant glioma	0.0011	0.00465	CcSEcCtD
Pentamidine—Anaemia—Carmustine—malignant glioma	0.00109	0.00458	CcSEcCtD
Pentamidine—Vision blurred—Temozolomide—malignant glioma	0.00107	0.00452	CcSEcCtD
Pentamidine—Tremor—Temozolomide—malignant glioma	0.00107	0.00449	CcSEcCtD
Pentamidine—Leukopenia—Carmustine—malignant glioma	0.00105	0.00444	CcSEcCtD
Pentamidine—Anaemia—Temozolomide—malignant glioma	0.00105	0.00443	CcSEcCtD
Pentamidine—CYP2D6—telencephalon—malignant glioma	0.00104	0.00994	CbGeAlD
Pentamidine—Angioedema—Temozolomide—malignant glioma	0.00104	0.00438	CcSEcCtD
Pentamidine—Vertigo—Temozolomide—malignant glioma	0.00102	0.00431	CcSEcCtD
Pentamidine—Convulsion—Carmustine—malignant glioma	0.00102	0.0043	CcSEcCtD
Pentamidine—Leukopenia—Temozolomide—malignant glioma	0.00102	0.00429	CcSEcCtD
Pentamidine—Hypertension—Carmustine—malignant glioma	0.00102	0.00428	CcSEcCtD
Pentamidine—Palpitations—Temozolomide—malignant glioma	0.001	0.00424	CcSEcCtD
Pentamidine—Chest pain—Carmustine—malignant glioma	0.001	0.00422	CcSEcCtD
Pentamidine—Myalgia—Carmustine—malignant glioma	0.001	0.00422	CcSEcCtD
Pentamidine—Anxiety—Carmustine—malignant glioma	0.000998	0.00421	CcSEcCtD
Pentamidine—Cough—Temozolomide—malignant glioma	0.000992	0.00418	CcSEcCtD
Pentamidine—Convulsion—Temozolomide—malignant glioma	0.000985	0.00415	CcSEcCtD
Pentamidine—Hypertension—Temozolomide—malignant glioma	0.000982	0.00414	CcSEcCtD
Pentamidine—Confusional state—Carmustine—malignant glioma	0.000968	0.00408	CcSEcCtD
Pentamidine—Myalgia—Temozolomide—malignant glioma	0.000968	0.00408	CcSEcCtD
Pentamidine—Arthralgia—Temozolomide—malignant glioma	0.000968	0.00408	CcSEcCtD
Pentamidine—Anxiety—Temozolomide—malignant glioma	0.000965	0.00407	CcSEcCtD
Pentamidine—Discomfort—Temozolomide—malignant glioma	0.000956	0.00403	CcSEcCtD
Pentamidine—Infection—Carmustine—malignant glioma	0.000954	0.00402	CcSEcCtD
Pentamidine—Dry mouth—Temozolomide—malignant glioma	0.000947	0.00399	CcSEcCtD
Pentamidine—Thrombocytopenia—Carmustine—malignant glioma	0.00094	0.00396	CcSEcCtD
Pentamidine—Tachycardia—Carmustine—malignant glioma	0.000937	0.00395	CcSEcCtD
Pentamidine—Confusional state—Temozolomide—malignant glioma	0.000936	0.00394	CcSEcCtD
Pentamidine—Anaphylactic shock—Temozolomide—malignant glioma	0.000928	0.00391	CcSEcCtD
Pentamidine—Infection—Temozolomide—malignant glioma	0.000922	0.00389	CcSEcCtD
Pentamidine—Anorexia—Carmustine—malignant glioma	0.000915	0.00386	CcSEcCtD
Pentamidine—Thrombocytopenia—Temozolomide—malignant glioma	0.000909	0.00383	CcSEcCtD
Pentamidine—Hypotension—Carmustine—malignant glioma	0.000897	0.00378	CcSEcCtD
Pentamidine—Anorexia—Temozolomide—malignant glioma	0.000885	0.00373	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000875	0.00369	CcSEcCtD
Pentamidine—Insomnia—Carmustine—malignant glioma	0.000869	0.00366	CcSEcCtD
Pentamidine—Paraesthesia—Carmustine—malignant glioma	0.000862	0.00364	CcSEcCtD
Pentamidine—Dyspnoea—Carmustine—malignant glioma	0.000856	0.00361	CcSEcCtD
Pentamidine—Somnolence—Carmustine—malignant glioma	0.000854	0.0036	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000845	0.00356	CcSEcCtD
Pentamidine—Insomnia—Temozolomide—malignant glioma	0.000839	0.00354	CcSEcCtD
Pentamidine—Decreased appetite—Carmustine—malignant glioma	0.000835	0.00352	CcSEcCtD
Pentamidine—Paraesthesia—Temozolomide—malignant glioma	0.000833	0.00351	CcSEcCtD
Pentamidine—Dyspnoea—Temozolomide—malignant glioma	0.000827	0.00349	CcSEcCtD
Pentamidine—Somnolence—Temozolomide—malignant glioma	0.000825	0.00348	CcSEcCtD
Pentamidine—Pain—Carmustine—malignant glioma	0.000821	0.00346	CcSEcCtD
Pentamidine—Constipation—Carmustine—malignant glioma	0.000821	0.00346	CcSEcCtD
Pentamidine—CYP1A1—central nervous system—malignant glioma	0.000818	0.00783	CbGeAlD
Pentamidine—Dyspepsia—Temozolomide—malignant glioma	0.000817	0.00344	CcSEcCtD
Pentamidine—Decreased appetite—Temozolomide—malignant glioma	0.000807	0.0034	CcSEcCtD
Pentamidine—Fatigue—Temozolomide—malignant glioma	0.0008	0.00337	CcSEcCtD
Pentamidine—Pain—Temozolomide—malignant glioma	0.000794	0.00335	CcSEcCtD
Pentamidine—Constipation—Temozolomide—malignant glioma	0.000794	0.00335	CcSEcCtD
Pentamidine—Feeling abnormal—Carmustine—malignant glioma	0.000791	0.00334	CcSEcCtD
Pentamidine—Gastrointestinal pain—Carmustine—malignant glioma	0.000785	0.00331	CcSEcCtD
Pentamidine—Feeling abnormal—Temozolomide—malignant glioma	0.000765	0.00322	CcSEcCtD
Pentamidine—Abdominal pain—Carmustine—malignant glioma	0.000759	0.0032	CcSEcCtD
Pentamidine—Body temperature increased—Carmustine—malignant glioma	0.000759	0.0032	CcSEcCtD
Pentamidine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000759	0.0032	CcSEcCtD
Pentamidine—Urticaria—Temozolomide—malignant glioma	0.000737	0.00311	CcSEcCtD
Pentamidine—Body temperature increased—Temozolomide—malignant glioma	0.000734	0.00309	CcSEcCtD
Pentamidine—Abdominal pain—Temozolomide—malignant glioma	0.000734	0.00309	CcSEcCtD
Pentamidine—Hypersensitivity—Carmustine—malignant glioma	0.000708	0.00298	CcSEcCtD
Pentamidine—CYP2C8—brain—malignant glioma	0.000704	0.00673	CbGeAlD
Pentamidine—Asthenia—Carmustine—malignant glioma	0.000689	0.0029	CcSEcCtD
Pentamidine—Hypersensitivity—Temozolomide—malignant glioma	0.000684	0.00288	CcSEcCtD
Pentamidine—Asthenia—Temozolomide—malignant glioma	0.000666	0.00281	CcSEcCtD
Pentamidine—Diarrhoea—Carmustine—malignant glioma	0.000657	0.00277	CcSEcCtD
Pentamidine—Pruritus—Temozolomide—malignant glioma	0.000657	0.00277	CcSEcCtD
Pentamidine—CYP1A1—brain—malignant glioma	0.00065	0.00621	CbGeAlD
Pentamidine—Dizziness—Carmustine—malignant glioma	0.000635	0.00268	CcSEcCtD
Pentamidine—Diarrhoea—Temozolomide—malignant glioma	0.000635	0.00268	CcSEcCtD
Pentamidine—Dizziness—Temozolomide—malignant glioma	0.000614	0.00259	CcSEcCtD
Pentamidine—Vomiting—Carmustine—malignant glioma	0.000611	0.00257	CcSEcCtD
Pentamidine—Rash—Carmustine—malignant glioma	0.000605	0.00255	CcSEcCtD
Pentamidine—Dermatitis—Carmustine—malignant glioma	0.000605	0.00255	CcSEcCtD
Pentamidine—Headache—Carmustine—malignant glioma	0.000602	0.00254	CcSEcCtD
Pentamidine—CYP3A4—central nervous system—malignant glioma	0.0006	0.00574	CbGeAlD
Pentamidine—CYP2D6—central nervous system—malignant glioma	0.000591	0.00565	CbGeAlD
Pentamidine—Vomiting—Temozolomide—malignant glioma	0.00059	0.00249	CcSEcCtD
Pentamidine—Rash—Temozolomide—malignant glioma	0.000585	0.00247	CcSEcCtD
Pentamidine—Dermatitis—Temozolomide—malignant glioma	0.000585	0.00246	CcSEcCtD
Pentamidine—Headache—Temozolomide—malignant glioma	0.000581	0.00245	CcSEcCtD
Pentamidine—CYP2D6—cerebellum—malignant glioma	0.000577	0.00552	CbGeAlD
Pentamidine—Nausea—Carmustine—malignant glioma	0.00057	0.0024	CcSEcCtD
Pentamidine—Nausea—Temozolomide—malignant glioma	0.000551	0.00232	CcSEcCtD
Pentamidine—CYP2D6—brain—malignant glioma	0.000469	0.00449	CbGeAlD
Pentamidine—S100B—Immune System—PTEN—malignant glioma	6.11e-05	0.000235	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ASMT—malignant glioma	6.1e-05	0.000234	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NOTCH1—malignant glioma	6.1e-05	0.000234	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—AKT1—malignant glioma	6.05e-05	0.000232	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.01e-05	0.000231	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CD80—malignant glioma	5.98e-05	0.00023	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—APC—malignant glioma	5.97e-05	0.000229	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CG—malignant glioma	5.97e-05	0.000229	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.96e-05	0.000229	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGF—malignant glioma	5.9e-05	0.000227	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.89e-05	0.000226	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—COX8A—malignant glioma	5.89e-05	0.000226	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTPN11—malignant glioma	5.86e-05	0.000225	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSTP1—malignant glioma	5.81e-05	0.000223	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—BCAN—malignant glioma	5.74e-05	0.00022	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.73e-05	0.00022	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CAT—malignant glioma	5.65e-05	0.000217	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—BRAF—malignant glioma	5.61e-05	0.000215	CbGpPWpGaD
Pentamidine—S100B—Immune System—STAT3—malignant glioma	5.46e-05	0.00021	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT2—malignant glioma	5.46e-05	0.00021	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ASMT—malignant glioma	5.45e-05	0.000209	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—IDH2—malignant glioma	5.34e-05	0.000205	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—NCOR1—malignant glioma	5.34e-05	0.000205	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.32e-05	0.000204	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CD—malignant glioma	5.25e-05	0.000201	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—BCAN—malignant glioma	5.12e-05	0.000197	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—IDH2—malignant glioma	5.04e-05	0.000194	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—FGF2—malignant glioma	5.02e-05	0.000193	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP2B6—malignant glioma	5.02e-05	0.000193	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ASMT—malignant glioma	5.01e-05	0.000192	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—COX8A—malignant glioma	4.99e-05	0.000192	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—malignant glioma	4.97e-05	0.000191	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.76e-05	0.000183	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP2B6—malignant glioma	4.74e-05	0.000182	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—BCAN—malignant glioma	4.71e-05	0.000181	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MDM2—malignant glioma	4.7e-05	0.00018	CbGpPWpGaD
Pentamidine—S100B—Immune System—KRAS—malignant glioma	4.69e-05	0.00018	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—RAF1—malignant glioma	4.68e-05	0.00018	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ERBB2—malignant glioma	4.63e-05	0.000178	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—IDH2—malignant glioma	4.62e-05	0.000178	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—IDH1—malignant glioma	4.59e-05	0.000176	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CB—malignant glioma	4.57e-05	0.000176	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.46e-05	0.000171	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SPHK1—malignant glioma	4.44e-05	0.000171	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL8—malignant glioma	4.39e-05	0.000169	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.36e-05	0.000168	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP2C18—malignant glioma	4.35e-05	0.000167	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CAV1—malignant glioma	4.35e-05	0.000167	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP2B6—malignant glioma	4.35e-05	0.000167	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—IDH1—malignant glioma	4.34e-05	0.000167	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CA—malignant glioma	4.31e-05	0.000166	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ASMT—malignant glioma	4.24e-05	0.000163	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CASP3—malignant glioma	4.21e-05	0.000162	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—malignant glioma	4.2e-05	0.000161	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SPHK1—malignant glioma	4.2e-05	0.000161	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.16e-05	0.00016	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.15e-05	0.000159	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—IDH2—malignant glioma	4.13e-05	0.000159	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP2C18—malignant glioma	4.11e-05	0.000158	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—BCAN—malignant glioma	3.99e-05	0.000153	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—IDH1—malignant glioma	3.98e-05	0.000153	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—malignant glioma	3.97e-05	0.000153	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CG—malignant glioma	3.96e-05	0.000152	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTEN—malignant glioma	3.95e-05	0.000152	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.89e-05	0.00015	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2B6—malignant glioma	3.88e-05	0.000149	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.88e-05	0.000149	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—COX8A—malignant glioma	3.85e-05	0.000148	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SPHK1—malignant glioma	3.85e-05	0.000148	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PPARG—malignant glioma	3.83e-05	0.000147	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—IDH2—malignant glioma	3.8e-05	0.000146	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP2C18—malignant glioma	3.77e-05	0.000145	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2B6—malignant glioma	3.57e-05	0.000137	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—malignant glioma	3.57e-05	0.000137	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.56e-05	0.000137	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—IDH1—malignant glioma	3.55e-05	0.000136	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT3—malignant glioma	3.53e-05	0.000136	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.53e-05	0.000136	CbGpPWpGaD
Pentamidine—S100B—Immune System—AKT1—malignant glioma	3.52e-05	0.000135	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTT1—malignant glioma	3.52e-05	0.000135	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CD—malignant glioma	3.48e-05	0.000134	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SPHK1—malignant glioma	3.44e-05	0.000132	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.41e-05	0.000131	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2C18—malignant glioma	3.37e-05	0.000129	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTT1—malignant glioma	3.33e-05	0.000128	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS1—malignant glioma	3.3e-05	0.000127	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—malignant glioma	3.28e-05	0.000126	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ASMT—malignant glioma	3.28e-05	0.000126	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—IDH1—malignant glioma	3.27e-05	0.000125	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.24e-05	0.000124	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—IDH2—malignant glioma	3.22e-05	0.000124	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—malignant glioma	3.21e-05	0.000123	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.17e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SPHK1—malignant glioma	3.16e-05	0.000121	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.13e-05	0.00012	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS1—malignant glioma	3.12e-05	0.00012	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.11e-05	0.000119	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2C18—malignant glioma	3.1e-05	0.000119	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—BCAN—malignant glioma	3.08e-05	0.000118	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—BCHE—malignant glioma	3.07e-05	0.000118	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTT1—malignant glioma	3.05e-05	0.000117	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CB—malignant glioma	3.04e-05	0.000117	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—malignant glioma	3.03e-05	0.000117	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.03e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.03e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.02e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—malignant glioma	3.01e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—BCHE—malignant glioma	2.9e-05	0.000111	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.89e-05	0.000111	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SLC5A5—malignant glioma	2.86e-05	0.00011	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS1—malignant glioma	2.86e-05	0.00011	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.85e-05	0.000109	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.79e-05	0.000107	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—malignant glioma	2.79e-05	0.000107	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—IDH1—malignant glioma	2.77e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTT1—malignant glioma	2.72e-05	0.000105	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.71e-05	0.000104	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—malignant glioma	2.7e-05	0.000104	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.68e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SPHK1—malignant glioma	2.68e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—BCHE—malignant glioma	2.66e-05	0.000102	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—malignant glioma	2.62e-05	0.000101	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SLC5A5—malignant glioma	2.62e-05	0.000101	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.62e-05	0.000101	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS1—malignant glioma	2.55e-05	9.8e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.54e-05	9.76e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTT1—malignant glioma	2.5e-05	9.61e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—IDH2—malignant glioma	2.48e-05	9.53e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.48e-05	9.53e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.47e-05	9.5e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.46e-05	9.44e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTP1—malignant glioma	2.44e-05	9.37e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CAT—malignant glioma	2.37e-05	9.12e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—BCHE—malignant glioma	2.37e-05	9.11e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS1—malignant glioma	2.35e-05	9.01e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.34e-05	9e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.34e-05	8.98e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.33e-05	8.96e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTP1—malignant glioma	2.31e-05	8.85e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—malignant glioma	2.28e-05	8.75e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.25e-05	8.65e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CAT—malignant glioma	2.24e-05	8.62e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NCOR1—malignant glioma	2.24e-05	8.61e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.21e-05	8.51e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.19e-05	8.43e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—BCHE—malignant glioma	2.18e-05	8.38e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.17e-05	8.35e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.15e-05	8.27e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.14e-05	8.24e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—IDH1—malignant glioma	2.13e-05	8.2e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTT1—malignant glioma	2.12e-05	8.15e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NCOR1—malignant glioma	2.12e-05	8.14e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTP1—malignant glioma	2.11e-05	8.12e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SPHK1—malignant glioma	2.07e-05	7.93e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CAT—malignant glioma	2.06e-05	7.9e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.02e-05	7.77e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS1—malignant glioma	1.99e-05	7.63e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.98e-05	7.6e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NCOR1—malignant glioma	1.94e-05	7.46e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.91e-05	7.35e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTP1—malignant glioma	1.89e-05	7.25e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—malignant glioma	1.85e-05	7.11e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—BCHE—malignant glioma	1.85e-05	7.1e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CAT—malignant glioma	1.84e-05	7.05e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CAV1—malignant glioma	1.83e-05	7.02e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.82e-05	7.01e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTP1—malignant glioma	1.74e-05	6.66e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NCOR1—malignant glioma	1.73e-05	6.66e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CAV1—malignant glioma	1.73e-05	6.63e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.73e-05	6.63e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.71e-05	6.57e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CAT—malignant glioma	1.69e-05	6.49e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.67e-05	6.4e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.65e-05	6.34e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTT1—malignant glioma	1.64e-05	6.29e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARG—malignant glioma	1.61e-05	6.17e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NCOR1—malignant glioma	1.59e-05	6.12e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CAV1—malignant glioma	1.58e-05	6.08e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—malignant glioma	1.57e-05	6.04e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS1—malignant glioma	1.53e-05	5.89e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARG—malignant glioma	1.52e-05	5.83e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.51e-05	5.81e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—malignant glioma	1.51e-05	5.81e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.49e-05	5.73e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTP1—malignant glioma	1.47e-05	5.65e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.46e-05	5.62e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.44e-05	5.54e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CAT—malignant glioma	1.43e-05	5.49e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—BCHE—malignant glioma	1.43e-05	5.48e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CAV1—malignant glioma	1.41e-05	5.43e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.41e-05	5.41e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARG—malignant glioma	1.39e-05	5.35e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.38e-05	5.31e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NCOR1—malignant glioma	1.35e-05	5.19e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.35e-05	5.19e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CAV1—malignant glioma	1.3e-05	4.99e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.29e-05	4.94e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.28e-05	4.9e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.27e-05	4.87e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—malignant glioma	1.26e-05	4.86e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARG—malignant glioma	1.24e-05	4.77e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.21e-05	4.63e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—malignant glioma	1.19e-05	4.59e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.18e-05	4.55e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARG—malignant glioma	1.14e-05	4.39e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTP1—malignant glioma	1.13e-05	4.36e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.13e-05	4.35e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CB—malignant glioma	1.11e-05	4.24e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CAT—malignant glioma	1.1e-05	4.24e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—malignant glioma	1.1e-05	4.23e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CAV1—malignant glioma	1.1e-05	4.23e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—malignant glioma	1.09e-05	4.21e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.05e-05	4.04e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.04e-05	4e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—malignant glioma	1.04e-05	4e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.04e-05	4e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—malignant glioma	1e-05	3.85e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CB—malignant glioma	9.86e-06	3.79e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—malignant glioma	9.77e-06	3.75e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARG—malignant glioma	9.68e-06	3.72e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—malignant glioma	9.55e-06	3.67e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CB—malignant glioma	9.07e-06	3.48e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—malignant glioma	8.99e-06	3.45e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CD—malignant glioma	8.82e-06	3.39e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—malignant glioma	8.52e-06	3.27e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CAV1—malignant glioma	8.5e-06	3.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—malignant glioma	7.84e-06	3.01e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—malignant glioma	7.78e-06	2.99e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.74e-06	2.97e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CB—malignant glioma	7.69e-06	2.95e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—malignant glioma	7.62e-06	2.92e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARG—malignant glioma	7.47e-06	2.87e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—malignant glioma	7.35e-06	2.82e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.81e-06	2.61e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—malignant glioma	6.74e-06	2.59e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—malignant glioma	6.64e-06	2.55e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—malignant glioma	6.35e-06	2.44e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—malignant glioma	6.01e-06	2.31e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—malignant glioma	6e-06	2.31e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.93e-06	2.28e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—malignant glioma	5.88e-06	2.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—malignant glioma	5.53e-06	2.12e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—malignant glioma	5.5e-06	2.11e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—malignant glioma	5.13e-06	1.97e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—malignant glioma	4.91e-06	1.89e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—malignant glioma	4.69e-06	1.8e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—malignant glioma	4.52e-06	1.74e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—malignant glioma	3.83e-06	1.47e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.62e-06	1.39e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—malignant glioma	2.95e-06	1.13e-05	CbGpPWpGaD
